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We report that tumor cells without mitochondrial
DNA (mtDNA) show delayed tumor growth, and that
tumor formation is associated with acquisition of
mtDNA from host cells. This leads to partial recovery
of mitochondrial function in cells derived from pri-
mary tumors grown from cells without mtDNA and
a shorter lag in tumor growth. Cell lines from circu-
lating tumor cells showed further recovery of mito-
chondrial respiration and an intermediate lag to
tumor growth, while cells from lung metastases ex-
hibited full restoration of respiratory function and
no lag in tumor growth. Stepwise assembly of mito-
chondrial respiratory (super)complexes was corre-
lated with acquisition of respiratory function. Our
findings indicate horizontal transfer of mtDNA from
host cells in the tumor microenvironment to tumor
cells with compromised respiratory function to re-
establish respiration and tumor-initiating efficacy.
These results suggest pathophysiological processes
for overcoming mtDNA damage and support the
notion of high plasticity of malignant cells.
INTRODUCTION
Mitochondria are structurally dynamic organelles with a circular
genome (mtDNA) of 16.5 kb in mammals that encodes 13
subunits of the respiratory complexes (RCs), 22 tRNAs, and
2 rRNAs. Cells contain both discreet and networked mito-
chondria each with multiple mtDNA copies. Replication and
transcription of mtDNA involves the regulatory D-LOOP region,Cwhich binds the nuclear-encoded mitochondrial transcription
factor TFAM and other regulatory proteins (Falkenberg et al.,
2007). The mitochondrial proteome comprises 1,500 proteins,
most of which are encoded by nuclear DNA (nDNA) (Neupert
and Herrmann, 2007; Wallace, 2012). A major role of mitochon-
dria, ATP generation, is facilitated by oxidative phosphorylation
(OXPHOS) comprising four complexes of the electron transport
chain (ETC), complex I (CI), CII, CIII and CIV, and CV with ATP
synthase activity. RCs form supercomplexes (SCs), such as the
respirasome (Scha¨gger and Pfeiffer, 2000; Acı´n-Pe´rez et al.,
2008; Althoff et al., 2011) that transfers electrons from CI to
CIV via CIII (Lapuente-Brun et al., 2013). RCs and SCs are
assembled stepwise in a process involving specific factors
(Moreno-Lastres et al., 2012; Lapuente-Brun et al., 2013; Ikeda
et al., 2013).
Due to the central role of mitochondria in homeostasis, cells
have conserved control systems to maintain mitochondrial
integrity, appropriate mitochondrial mass, and bioenergetic
and metabolic functions. In many pathologies, mtDNA muta-
tions affect tissues with high demand for energy (Krishnan
et al., 2008; Lu et al., 2009; Schon et al., 2012; Wallace,
2012). Cancer is characterized by altered energy metabolism
(DeBerardinis et al., 2007; Kroemer and Pouyssegur, 2008; Van-
der Heiden et al., 2009; Ralph et al., 2010; Hanahan and Wein-
berg, 2011) involving not only genetic alterations in nDNA, but
also mtDNA mutations and changes in mtDNA copy number
(Surani, 2001; Wallace and Fan, 2010; De Carvalho et al.,
2010; Plass et al., 2013). Certain mtDNA mutations compromise
ETC function and contribute to a shift to aerobic glycolysis that
typifies metastatic progression (Ishikawa et al., 2008; Ralph
et al., 2010). Relevant studies are limited by the difficulty of
experimentally manipulating mtDNA of tumor cells and the
paucity of tumor models with mtDNA mutations. A model of se-
vere mtDNA damage involves mitochondrial genome deletion
(King and Attardi, 1988). These r0 cells grow in culture withell Metabolism 21, 81–94, January 6, 2015 ª2015 Elsevier Inc. 81
uridine and pyruvate supplementation, but the question of
whether they can form tumors following autologous transplanta-
tion has not been studied.
We have developed two stable murine tumor cell models lack-
ing mtDNA and investigated whether these cells form tumors in
syngeneic mice. Our results show delayed tumor growth and
acquisition of mtDNA from host cells. Cells derived from primary
tumors that grow from r0 cells and from their circulating and
metastatic counterparts progressively recovered mitochondrial
respiratory function, and this was associated with assembly of
mitochondrial SCs and correlated with tumorigenicity.
RESULTS
Tumor Cells Devoid of mtDNA Show Delayed Tumor
Growth
To model severe mitochondrial genome damage, we deleted
mtDNA in metastatic murine B16 melanoma and 4T1 breast
carcinoma cells using low-dose ethidium bromide (EtBr),
thereby generating B16r0 and 4T1r0 cells that have been main-
tained as stable auxotrophic cell lines without EtBr for more
than 2 years. When injected subcutaneously (s.c.) into groups
of five syngeneic C57BL/6 (n = 3 experiments) or NOD/scid
(n = 3 experiments) mice, B16r0 cells (105) initiated tumors
with a delay of more than 20 days compared to parental cells
(Figure 1A). Intravenous (i.v.) injection of B16r0 cells into
NOD/scid mice failed to generate lung tumors. However, cell
lines derived from s.c. tumors and lung metastases that grew
from B16r0 cells following long-term culture formed lung tu-
mors at a similar frequency to B16 cells (Figure 1A). These
cell lines were shown to be of B16, rather than mouse origin,
because they produced melanin under stress. Similarly, 4T1r0
cells formed tumors with a lag of 20–25 days when 105 cells
were injected s.c. (n = 6 experiments) or orthotopically into
the mammary fat pad (n = 1 experiment) of Balb/c mice, but
failed to form lung tumors following i.v. injection (Figure 1B)
or following s.c. injection of % 104 cells (Figure S1 available
online).
As 4T1 and 4T1r0 cells are resistant to 6-thioguanine (6TG), we
used 20 mM 6TG to select cell lines from primary tumors that
formed from 4T1r0 cells (4T1r0SC), circulating tumor cells
(4T1r0CTC), and lung metastases (4T1r0SCL). When injected
i.v., both 4T1r0SC and 4T1r0SCL cells, and a cell line derived
from lung metastases that formed from an orthotopic tumor
(4T1roMFPL), formed lung tumors that were comparable to
4T1 cells (Figure 1B). When injected s.c. into Balb/c mice,
4T1r0SC cells formed tumors with a delay of10 days, whereas
4T1r0SCL cells initiated tumors without a lag (Figure 1C; n = 2
experiments). 4T1r0CTC cells formed tumors with a lag between
that of 4T1r0SC and 4T1r0SCL cells.
To investigate whether acquisition of tumorigenic properties is
associated with respiratory competence, tumors that formed
from 4T1, 4T1r0, and derived cell lines were assessed by high-
resolution respirometry. Relative to cells from parental tumors,
respiration by tumors that grew from 4T1r0 cells was reduced
by 60%, whereas 4T1r0SC, 4T1r0CTC, and 4T1r0SCL cell-
derived tumors exhibited progressive recovery of respiration
(Figure 1D). Histological examination of tumors derived from
each cell line showed qualitative similarities (Figure 1E).82 Cell Metabolism 21, 81–94, January 6, 2015 ª2015 Elsevier Inc.Tumors Derived from r0 Cells Contain Host Mouse
mtDNA and Exhibit Functional Mitochondrial Protein
Synthesis
PCR analysis of the mtDNA-encoded Cytb gene revealed no
product in B16r0 or 4T1r0 cells confirming the absence of
mtDNA in these cells (Figure 2A). These results rule out possible
contribution from nuclear mitochondrial DNA sequences (Schon
et al., 2012). However, Cytb was present in B16r0SC and
B16r0SCL cells. Similar results were obtained with 4T1r0SC
and 4T1r0SCL cells (Figure 2A). To investigate the origin of the
mtDNA in these cells, we sequenced the mtDNA region contain-
ing the polymorphic tRNAArg locus. Cells from both B16r0- and
4T1r0-derived tumors showed the polymorphism of the host
mouse (Bayona-Bafaluy et al., 2003), rather than that of B16
and 4T1 cells (Figure 2B), demonstrating acquisition of mtDNA
from host cells in the tumormicroenvironment (eight consecutive
adenines for C57BL/6 and nine for NOD/scid and Balb/c mice) to
r0 tumor cells in each model. To verify the host origin of mtDNA,
we sequenced whole mtDNA from B16, B16r0SC, 4T1, and
4T1r0SC cells using next-generation Ion Torrent and Nanopore
MinION methodologies. These approaches identified two addi-
tional polymorphisms in 16SrRNA (site 1,576) and D-loop (site
16,076) that distinguished 4T1 from 4T1r0SC cells (Table S1),
verifying that mtDNA in tumors derived from 4T1r0 cells was
from the recipient mouse. No additional polymorphisms were
observed in B16 and B16r0SC cells. Taken together, these find-
ings unequivocally demonstrate that mtDNA in tumors derived
from r0 cells originate from the recipient mouse. Mitochondrial
protein synthesis was shown to be functional in cell lines derived
from tumors from B16r0 and 4T1r0 cells by the presence of COI,
an mtDNA-encoded protein (Figure 2C).
Distinct Phenotypic Properties and Mitochondrial
Morphology of 4T1r0 Cells following mtDNA Acquisition
Acquisition of host mtDNA by r0 tumor cells prompted us to
investigate the phenotypic and morphological properties of the
4T1r0-derived sublines (4T1r0SC, 4T1r0CTC, and 4T1r0SCL
cells). We also investigated ‘‘matching’’ cells derived from s.c.
tumors (4T1SC cells) and lung metastases (4T1SCL cells) that
grew from parental 4T1 cells. The doubling times of these cell
lines were as follows: 4T1, 18.7 hr; 4T1SC, 17.5 hr; 4T1SCL,
16 hr; 4T1r0, 33.6 hr; 4T1r0SC, 21.5 hr; 4T1r0CTC, 23.1 hr;
and 4T1r0SCL, 16.1 hr. Light microscopy revealed morpholog-
ical differences of individual sublines (Figure 3A). In agreement
with the PCR analysis of mtDNA (Figure 2A), staining with EtBr
confirmed the absence of mtDNA in 4T1r0 cells, showing only
nucleolar staining. Costaining with MitoTracker Red showed
high mtDNA heterogeneity in 4T1r0SC and to a lesser extent in
4T1r0CTC cells. Flow cytometric analysis revealed that 60%
of 4T1r0SC cells contained little or no mtDNA, while almost
90% of 4T1r0CTC and 100% of 4T1r0SCL cells contained
mtDNA (Figure 3B). 4T1SC cells showed similar mtDNA staining
to that found in 4T1 and 4T1SCL cells (Figure S2A).
We tested individual sublines for their autophagic status,
reasoning that 4T1r0SC cells may exhibit higher mitophagy to
remove respiration-defective mitochondria devoid of mtDNA.
Initial acridine orange (AO) staining showed heterogeneous
acidic vesicles in 4T1r0SC cells, and western blotting (WB) re-
vealed lower levels of the autophagy marker LC3B-II in 4T1r0
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Figure 1. Tumor Cells without mtDNA Show Delayed Tumor Growth
(A) B16 and B16r0 cells (105) were injected s.c. into C57BL/6 or NOD/scid mice, and tumor growth was monitored. These cells and cell lines derived from s.c.
tumors and lung metastases that grew from B16r0 cells were also injected i.v. into NOD/scid mice, and lung weight and tumor colonies were determined.
(B) 4T1 and 4T1r0 cells were injected s.c. or orthotopically into the mammary fat pad of Balb/c mice, and tumor growth was monitored. These cells and 6TG-
resistant cell lines derived from s.c. tumors and lung metastases that grew from 4T1r0 cells were also injected i.v. into Balb/c mice, and lung weight and tumor
colonies were determined. Images of lungs from these mice are also shown.
(C) 4T1, 4T1r0, 4T1r0SC, 4T1r0CTC, and 4T1r0SCL cells were injected into Balb/c mice, and tumor growth was monitored.
(D) Oxygen consumption by tissue of tumors derived from cells as stated above (C) was compared with respiration of liver tissue obtained from the same mice.
(E) Histological staining of tissue sections from (C) stained with H&E; scale bar, 20 mm. Data are from three independent experiments, and the results are ex-
pressed as mean ± SD. The symbol * denotes significant differences with p < 0.05 and ** p < 0.001.and 4T1r0SC cells than in 4T1r0CTC and 4T1r0SCL cells, and
higher levels of p62 in 4T1r0SC cells, both with control cells
and cells treated with the autophagy inhibitor bafilomycin A1C(Figure 3C). The mitophagy marker, Parkin, showed increased
expression in cells derived from 4T1r0 and highest expression
in 4T1r0SCL cells, but BNIP3 expression remained unalteredell Metabolism 21, 81–94, January 6, 2015 ª2015 Elsevier Inc. 83
Figure 2. Tumors Derived from Cells without mtDNA Contain mtDNA of Host Origin
(A) Left panels: Cytb PCR analysis of B16, B16r0, and B16r0SC and B16r0SCL tumor sublines from C57BL/6 (upper-left panel) and NOD/scid mice (lower-left
panel). Right panels: Cytb PCR analysis of 4T1, 4T1r0, and tumor sublines from orthotopic primary and metastatic tumors (upper-right panel, 4T1r0MFP,
4T1r0MFPL) and s.c. primary and metastatic tumors (4T1r0SC, 4T1r0SCL) that form in Balb/c mice.
(legend continued on next page)
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in the sublines. Since individual sublines were derived from
different stages of metastatic tumor progression, we investi-
gated markers of epithelial-mesenchymal transition (EMT). Fig-
ure 3D shows that the sublines differed coordinately in the level
of expression of E-cadherin and vimentin consistent with their
different origin.
Investigation of mitochondrial morphology by transmission
electron microscopy (TEM) revealed that mitochondria of
4T1r0 cells were distended with low-density internal staining
and were largely free of stacked cristae, but contained ring-like
cristae (Figure 4). Intriguingly, 4T1r0SC cells showed mitochon-
dria with and without cristae, while 4T1r0CTC cells contained
more mitochondria with cristae. 4T1r0SCL cells were indistin-
guishable from parental 4T1 cells and the matching tumor cells
(Figures 4 and S2B).
Bioenergetics and Mitochondrial Function following
mtDNA Acquisition
Cells devoid of mtDNA use glycolysis as a source of ATP.
Compared to parental 4T1 cells, 4T1r0, 4T1r0SC, and
4T1r0CTC cells showed elevated glucose uptake, increased
production of lactate, and lower levels of ATP (Figures 5A–5C).
In contrast, 4T1r0SCL cells were less glycolytic andmore similar
to parental 4T1 cells, as were the matching sublines (Figures
S3A–S3C). Cellular bioenergetic status and the efficiency of
mitochondrial respiration modulate production of reactive oxy-
gen species (ROS). We used the mitochondrially targeted probe,
MitoSOX, as an indicator of mitochondrial superoxide genera-
tion. Cell lines from primary tumors that developed from 4T1r0
cells when injected s.c. or into the mammary fat pad showed
distinct intermediate and high fluorescence intensity peaks,
while cells from lung metastases showed predominantly a high
fluorescence intensity peak comparable with parental 4T1 cells
(Figure S4A). Only the intermediate peak was present in 4T1r0
cells. Similar results were obtained with B16 cells (Figure S4B).
Quantitation of MitoSOX staining showed low fluorescence in
4T1r0 cells with other sublines being comparable with parental
4T1 cells (Figure 5D). Dihydrodichlorofluorescein (DCF) mea-
surement of cytosolic hydrogen peroxide showed a nonsignifi-
cant decrease in the signal in 4T1r0, 4T1r0SC, and 4T1r0SCL
cells relative to parental 4T1 cells (Figure 5E). Using TMRM as
a probe, mitochondrial membrane potential (DJm) was found
to be similar in 4T1 and 4T1r0 cells, elevated in 4T1r0SCL and
to a lesser extent in 4T1r0SC cells, and was greatly reduced in
4T1r0CTC cells (Figure 5F).
Respiration Recovery following mtDNA Acquisition by
4T1r0 Cells
4T1r0 cells showed barely detectable respiration, which was low
in 4T1r0SC cells and higher in 4T1r0CTC cells, while 4T1r0SCL
cells respired at a similar rate to parental cells (Figures 5G and
S5A). Respiration was similar in 4T1 and 4T1SC cells and slightly
lower in 4T1SCL cells (Figure S3F). Respiration via CI andCII was(B) Left panels: sequence analysis of the polymorphic region (9,817–9,836 C57B
and NOD/scid mice and from s.c. tumors derived from B16ro cells grown in C57
mitochondrial tRNAArg gene from Balb/c mice and from a s.c. tumor derived from
(C) COI immunocytochemical staining (green) of parental and r0 cells and indiv
Scale bar, 10 mm.
Cvery low in 4T1r0SC cells and higher in 4T1r0CTC cells. Respira-
tion via CI was similar in parental cells and 4T1r0SCL, while
respiration via CII was highly elevated in metastatic cells (Figures
5H and S5B). A similar respiration profile was found for isolated
mitochondria (Figure S5C), indicating that respiration of the
sublines is primarily governed by mitochondria, and not the ex-
tramitochondrial compartment. Collectively, these results show
significant differences in respiration of individual 4T1r0-derived
sublines, which paralleled the efficacy of these cells to initiate
tumor growth (Figure 1C).
mtDNA Recovery and Transcription following mtDNA
Acquisition
To determine whether phenotypic differences in 4T1r0-derived
sublines following mtDNA acquisition were related to gradual
restoration of mtDNA, we evaluated the mtDNA/nDNA ratio.
While 4T1r0 cells did not contain mtDNA, we found a several-
fold increase in the mtDNA/nDNA ratio in 4T1r0SC compared
to parental cells. This ratio was maintained over several months
of cell culture (Figure 6A). The notion of no mtDNA is corrobo-
rated by no product in both B16r0 and 4T1r0 cells when ampli-
fying whole cell mtDNA for NGS (Figure S6). 4T1r0CTC and
4T1r0SCL cells showed mtDNA/nDNA ratios more similar to
those of parental cells as did the corresponding 4T1SC and
4T1SCL cells (Figure S3G). Transcripts of mtDNA-encoded
genes were not detected in 4T1r0 cells, but were found in
4T1r0-derived sublines. Relative to 4T1 cells, Nd1, Nd2, Nd4,
Nd4l, Nd5, Nd6, and mt-Co2 were elevated 2- to 4-fold in
4T1r0SC cells, and Nd1, Nd2,mt-Co2, Atp6, and Atp8 elevated
1.5- to 4.5-fold in 4T1r0SCL cells. The level of D-loop transcript
was similar in all 4T1r0-derived sublines, indicating that the reg-
ulatory region of mtDNA does not hinder mtDNA replication or
transcription in these cells (Figure 6B).
nDNA-encoded subunits of mitochondrial complexes, with the
exception of Sdhc, showed a similar expression pattern indi-
cating a common transcription mechanism (Figure 6C). Of the
regulatory genes, relative expression of mRNA for the mitochon-
drial transcription factor Tfam was very low in 4T1r0 and almost
3-fold higher in 4T1r0SC cells, but was detected at similar levels
in 4T1, 4T1r0CTC, and 4T1r0SCL cells (Figure 6D). The Tfam
transcript profile in the sublines mirrors the mtDNA/nDNA ratios,
suggesting a causal relationship. Nrf1, Nrf2, Tfb1m, Tfb2m, and
Top1m transcripts were depressed in 4T1r0SC cells, while the
assembly factor Scafi (Cox7a2l) was decreased in 4T1r0,
4T1r0SC, and 4T1r0CTC cells, and the assembly factor Hig2a
was relatively unchanged. No differences in these transcripts
were observed in the matching cells (Figure S3H).
Mitochondrial Protein Synthesis, Citrate Synthase, and
CII Activity following mtDNA Acquisition
We next studied translation of mtDNA-encoded proteins. Fig-
ure 7A shows only background staining in 4T1r0 cells, with the
proteins coordinately expressed 2- to 3-fold higher in the otherL/6 reference NC_005089.1) of the mitochondrial tRNAArg gene from C57BL/6
BL/6 and NOD/scid mice. Right panels: comparable sequence analysis of the
4T1r0 cells grown in Balb/c mice. A summary table is presented.
idual sublines from r0 cells. Nuclei were stained with Hoechst 33342 (blue).
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Figure 4. TEM Analysis of 4T1r0 Sublines Shows Mitochondrial Ultrastructural Differences
4T1 cells and derived sublines were grown on coverslips, processed for TEM, and examined using TEM. The lower graphs indicate percent mitochondria with
visible cristae (left) and percent mitochondria with ring-like cristae (right) for each subline. The percentage of mitochondria with visible cristae in 4T1 cells was set
as 100%, the percentage of mitochondria with ring-like cristae in 4T1r0 cells set as 100%. Data are from three independent experiments, and the results are
expressed as mean ± SD. The symbol * denotes significant differences with p < 0.05.sublines compared to parental cells. Activity of citrate synthase
(CS), the first enzyme of the TCA cycle, was increased 2.5-fold
in 4T1r0 and 4T1r0SC cells, while in 4T1r0CTC and 4T1r0SCL
cells the activity was similar to that in parental cells (Figure 7B).
This increase was not observed in the corresponding sublines
(Figure S3I). We did not see amajor difference in succinate dehy-
drogenase (SDH) activity in sublines derived from 4T1r0 cells
(Figure 7C) or thematching cells (Figure S3J). Succinate quinone
reductase (SQR) activity of CII was very low in 4T1r0, 4T1r0SC,
and 4T1r0CTC cells, while in 4T1r0SCL cells it was 70% higher
than in 4T1 cells (Figure 7D). SQR activity was about 2-foldFigure 3. Parental 4T1- and 4T1r0-Derived Cell Lines Differ in Morphol
(A) 4T1 and derived sublines were evaluated using light microscopy.
(B) Sublines were stained with EtBr and MitoTracker Red, and confocal microsco
Nuclei were stained with Hoechst 33342 (blue). The percentage of cells with (up
cytometry.
(C) Sublines were incubated with AO (red) to visualize acidic vacuoles and with Ho
p62, Parkin, and BNIP3 with actin as loading control. Bafilomycin A treatment (2
(D) Sublines were incubated with E-cadherin (green) and vimentin (red) and coun
Chigher in the metastatic 4T1SCL cells than in 4T1 and 4T1SC
cells (Figure S3K).
RC Assembly and Subunit Expression following mtDNA
Acquisition
The expression of RC subunit proteins encoded by mtDNA and
nDNA, as well as proteins with a regulatory or general role in
mitochondria, was investigated in 4T1r0-derived cell lines
and control cells (Figures 7E and S3L). Nuclear-encoded CI
subunits NDUFS3 and NDUFA9 were not expressed in 4T1r0
cells, but were expressed in all other cell lines. The CII subunitogy and Phenotype
py was used to identify yellow (EtBr) and red (MitoTracker Red) fluorescence.
per-right quadrant) and without (left quadrants) mtDNA was evaluated by flow
echst 33342 to show nuclei (blue). Cells were also probed byWB for LC3B-I/II,
0 nM, 16 hr) was included in the LC3BII analysis to determine autophagic flux.
terstained with Hoechst 33342 and inspected by confocal microscopy.
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Figure 5. Bioenergetic Properties of 4T1r0
Sublines
4T1 cells and derived sublines were assessed for
glucose uptake (A), lactate production (B), and
ATP level (C). Mitochondrial superoxide genera-
tion was evaluated using MitoSOX (D), cytosolic
hydrogen peroxide with DCF (E), and DJm using
TMRM (F). (G) Cells were evaluated for routine,
leak, net (R–L), and uncoupled (ETS) respiration
using an Oxygraph respirometer. (H) Cells were
permeabilized with digitonin and evaluated for
respiration at the presence of substrates specific
for CI and CII. Data are from three independent
experiments, and the results are expressed as
mean ± SD. The symbol * denotes significant dif-
ferences with p < 0.05.SDHA was highly expressed in all cell lines, while SDHB was
expressed at lower levels in 4T1r0, 4T1r0SC, and 4T1r0CTC
cells. The assembly factor SDHAF2 that flavinates SDHA was
expressed in all cell lines, but was detected at higher levels
in 4T1roSC cells, while the nuclear-encoded CIII protein
Core2 was expressed in all sublines and was lowest in 4T1r0
cells. Nuclear-encoded CV ATPaseb was expressed at similar
levels in all sublines. The mtDNA-encoded COI and nDNA-en-
coded COIV subunits were not expressed in 4T1r0 cells, but
COI was expressed highly in 4T1r0SC cells. Nuclear-encoded
proteins that are not part of RCs were expressed in all sublines
with Cyt c being particularly high in 4T1r0 cells, and TIM23 and
VDAC1 attenuated in these cells. PGCa/b that regulates the
transcription factors NRF1/NRF2 was weakly expressed in
4T1r0 cells. OPA1, which modulates cristae formation and ge-
ometry, was also low in 4T1r0 and 4T1r0SC cells, but progres-
sively increased in 4T1r0CTC and 4T1r0SCL cells and was
highly expressed in matching 4T1SC and 4T1SCL cells
(Figure S3L).
Native blue gel electrophoresis (NBGE) using a mild detergent
followed by WB was used to assess the assembly of individual88 Cell Metabolism 21, 81–94, January 6, 2015 ª2015 Elsevier Inc.RCs and SCs (Figure 7F). Parental cells
showed a high level of the fully assem-
bled respirasome (CI+CIII2+CIVn), which
was absent in 4T1r0 cells. Lower respira-
some levels were observed in 4T1r0SC
cells and 4T1r0CTC cells, with full resto-
ration in 4T1r0SCL cells. Free CI, CIII in
the form of a dimer and in an SC with
CIV, and CIV largely in the form of a
monomer, were present at similar levels
in all cell types except for 4T1r0 cells.
CV was partially assembled in 4T1r0
cells due to the absence of structural
mtDNA-encoded ATP6 and ATP8, while
it was fully assembled and present as
a dimer in all other cell types. CII
was represented in 4T1r0 cells by the
highly expressed SDHA subunit. SDHB,
only observed in fully assembled CII,
was lower in 4T1r0, 4T1r0SC, and
4T1r0CTC than in 4T1 cells and elevatedby 70% in 4T1r0SCL cells. These findings demonstrate that
transition from 4T1r0CTC to 4T1r0SCL cells yields a fully
assembled respirasome and CII, associated with efficient respi-
ration and tumor initiation.
DISCUSSION
Whole-genome approaches have deepened our understanding
of the role of mutations in nDNA in different cancers (Kandoth
et al., 2013; Khurana et al., 2013). Mutations in mtDNA have
also been described in cancer, but their contribution to tumor
initiation, progression, and metastasis is less clear (Brandon
et al., 2006; Wallace, 2012; Schon et al., 2012). Functionally rele-
vant mtDNA mutations may compromise mitochondrial respira-
tion and promote aerobic glycolysis, a bioenergetic trait of many
tumors. In breast cancer, mtDNA mutations and low mtDNA
copy number are associated with increased metastasis and
poor prognosis (Petros et al., 2005, Tseng et al., 2006), and a
recent study showed that low mtDNA copy number promotes
metastasis by inducing EMT via mitochondrial retrograde
signaling (Guha and Avadhani, 2013).
Usingmetastatic murine tumormodels withmtDNA deletion to
simulate severe mtDNA damage, we have found a long lag to tu-
mor formation for both B16r0 melanoma and 4T1r0 breast carci-
noma cells in C57BL/6 and Balb/c mice, respectively, as well as
in NOD/scid mice. Previous reports on grafting human r0 tumor
cells have provided variable results, depending on tumor type,
the site of injection, and the recipient mouse (Hayashi et al.,
1992; Morais et al., 1994; Cavalli et al., 1997; Magda et al.,
2008; Kulawiec et al., 2008; Imanishi et al., 2011). In bothmodels,
we observed delayed tumor growth that was associated with
mtDNA acquisition from the host suggestive of horizontal mtDNA
transfer. This was demonstrated when cells derived from tumors
that grew from B16r0 and 4T1r0 cells were found to be positive
for both the Cytb gene and COI protein. We excluded the possi-
bility of latent mtDNA being present in r0 cells by showing that
tumors growing from B16r0 and 4T1r0 cells contained the
tRNAArg gene polymorphism of the recipient mouse (Bayona-Ba-
faluy et al., 2003), which is distinct from that of the original tumor.
Two additional 4T1 polymorphisms, D-loop and 16S rRNA, were
identical in 4T1r0SC cells and the recipient mouse. Although our
results cannot formally disprove the possibility of residual latent
mtDNAbeing present in r0 cells, and that low-level heteroplasmy
might occur at any particular polymorphic site in this latent
mtDNA, the probability that latency and homoplastic conversion
at all three sites could explain our results is considered to be
exceedingly remote.
Because there is no known mechanism for intercellular
transfer of mtDNA across both mitochondrial inner and outer
membranes and the plasma membrane, transfer of whole mito-
chondria is most likely. This has previously been shown to
occur in vitro (Spees et al., 2006; Cho et al., 2012; Gerdes
and Carvalho, 2008; Gurke et al., 2008) and in a mouse model
of acute lung injury, showing mitochondrial transfer from
mesenchymal stem cells (MSCs) injected into the animal’s
lungs (Islam et al., 2012). Organelle transfer between cells
has been reviewed recently, with a number of reports docu-
menting mitochondrial transfer (Rogers and Bhattacharya,
2013). Phylogenetic evidence also supports mtDNA transfer
between cells as shown in a transmissible canine venereal
tumor (Rebbeck et al., 2011).
To better understand the role of mitochondrial respiration in
tumorigenesis and metastasis, we characterized malignant
cells from different tumor microenvironments in the 4T1r0
model. To ensure that the results relate to mtDNA acquisition
and not local microenvironment, we isolated matching cell lines
from primary s.c. 4T1 tumors and lung metastases. Interest-
ingly, we found that cells derived from primary tumors that
grew from 4T1r0 cells still exhibited a considerable delay in
tumor initiation, while the kinetics of growth of tumors derived
from the metastatic 4T1r0SCL cells showed no delay. These
findings, initially acquired in our laboratory in Wellington and
repeated with almost identical results in our laboratory in
Prague 9 months later, indicate the robust nature of these
results and high reproducibility.
A striking finding is the stepwise recovery of mitochondrial
respiration from undetectable levels in r0 cells to low levels in pri-
mary tumor cells derived from r0 cells, progressing to higher
levels of respiration in CTCs and full restoration in metastatic
cells. The phenotype of the individual cell types was maintainedCin culture, as documented by sustained high mtDNA/nDNA ratio
in cells from the primary tumor. This suggests that these cells are
unable to restore full mitochondrial function during long-term
maintenance in vitro and need microenvironmental exposure to
progress to full respiratory competence. Our findings are consis-
tent with earlier in vitro results (Spees et al., 2006) showing that
mitochondrial transfer from MSCs and skin fibroblasts to human
A549r0 lung adenocarcinoma cells restored their respiratory
capacity.
We show detailed analysis of the individual stages of recovery
of respiratory competence from parental cells to their metasta-
tic counterparts, documenting each ‘‘recovery’’ stage. A crucial
step of full respiration recovery is associated with the assembly
of the respirasome and CII, demonstrating the need for fully
functional OXPHOS. This is also supported by the high level of
SQR activity in metastatic cells and agrees with the requirement
for efficient OXPHOS in metastatic dissemination (LeBleu et al.,
2014). In addition, we show that the level of the assembly factor
SCAFI (Lapuente-Brun et al., 2013), but not HIG2A (Moreno-
Lastres et al., 2012), correlates with the extent of respirasome
assembly in tumors derived from 4T1r0 cells. The key regulatory
role of SCAFI and other respirasome assembly factors in the
tumor microenvironment in metastatic progression needs
further investigation. Similarly, the reasons for full assembly of
CII in metastatic cells are not known, but are likely linked to
retrograde mitochondrial signaling. That the assembly of RCs
and SCs is crucial for the full recovery of mitochondrial respira-
tion is demonstrated by our findings that except for r0 cells,
all sublines of these cells exhibited transcriptional and transla-
tional activity of mtDNA-encoded genes, with partially or fully
assembled CI, CIII, and CIV. A key to understanding the different
behavior of the sublinesmay relate to the high level of mitochon-
drial heterogeneity.
A fundamental question raised by our findings relates to how
r0 cells, having acquired mtDNA, progress from primary tumor
via the circulation to lung metastases, and how this progression
leads to full recovery of respiration. In our model, metastatic po-
tential is encoded in the nuclear genome, but suppressed by the
absence of mtDNA. Acquisition of ‘‘normal’’ mtDNA from the
microenvironment enables 4T1r0 cells to grow as primary tu-
mors and ‘‘unleashes’’ their metastatic potential. It is possible
that rare cells acquire a few mitochondria that contain mtDNA,
and that these cells replicate their mtDNA, build cisternal struc-
tures of cristae, andmultiply clonally at the expense of cells lack-
ing mtDNA that are progressively eliminated by autophagy. Our
finding that autophagic activity is low in 4T1r0 and 4T1r0SC cells
that also feature lower respiration is consistent with a report
showing faulty autophagy in cells with suppressed ETC (Graef
and Nunnari, 2011). Such cells do not appear to ‘‘clear’’ dysfunc-
tional mitochondria, which is more likely to occur at the stage of
CTCs when respiration is partially restored and autophagy
higher.
Quantitation of mtDNA/nDNA ratios showed stable elevation
in 4T1r0SC cells, consistent with high levels of TFAM, a factor
critical for replication, transcription, and packaging of mtDNA
(Kukat and Larsson, 2013). Compromised respiration is corre-
lated with lack of cristae in all 4T1r0 cells and poorly formed
cristae in many 4T1r0SC cells, consistent with low OPA1 levels
(Cogliati et al., 2013). The reasons why r0 cells that haveell Metabolism 21, 81–94, January 6, 2015 ª2015 Elsevier Inc. 89
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acquired mtDNA require conditioning by the local microenviron-
ment to restore a parental intracellular distribution of mtDNA
might relate to progressive changes in mitochondria-to-nucleus
retrograde signaling that eventually normalizes both mtDNA dis-
tribution and respiratory function. The importance of the tumor
microenvironment is corroborated by the finding that 4T1 cells
show both epithelial and mesenchymal markers, highly localized
within the cell and exhibiting different patterns of compartmen-
talization, with coordinate changes in E-cadherin and vimentin
staining across 4T1 cells and derived sublines consistent with
the different origins of the individual 4T1 sublines.
The signaling mechanism that r0 cells employ to acquire
mtDNA from stromal cells and how this process occurs is un-
clear. It has been proposed that cells form tunneling nanotubes
to move biomaterial between cells (Rustom et al., 2004; Gerdes
and Carvalho, 2008), as shown for the mobilization of organ-
elles (Rustom et al., 2004; Koyanagi et al., 2005; Lou et al.,
2012; Islam et al., 2012; Pasquier et al., 2013), a process sup-
pressed by cytochalasin B (Bukoreshtliev et al., 2009). Other
mechanisms of organelle trafficking between cells have also
been proposed including membrane vesicles, cell fusion, and
various other cytoplasmic bridging processes. Of importance
is the minimum level of mtDNA damage needed to initiate inter-
cellular transfer of functional mitochondria. A gradual decrease
in the number of mtDNA copies in human glioblastoma cells
eventually resulted in a phenotype unable to recover in vitro,
while injecting these cells into immunocompromised mice led
to delayed formation of tumors and restoration of mitochondrial
function (Dickinson et al., 2013). Another important question re-
lates to how recovering mitochondria signal to the nucleus to
trigger transcription of genes needed for mitochondrial func-
tion. Retrograde mitochondrial signaling is poorly understood
at present and may include the bioenergetic status of the cell
(e.g., the AMP/ATP ratio), the level of ROS, release of metabo-
lites and Ca2+, etc. (Liu and Butow, 2006; Moreno-Loshuertos
et al., 2006; Ryan and Hoogenraad, 2007, Guha and Avadhani,
2013).
In conclusion, we have shown that tumor cells devoid of
mtDNA, a model of extreme mtDNA damage, can acquire
mtDNA of host origin, resulting in stepwise recovery of respi-
ration from primary to metastatic tumor cells. We show that a
crucial aspect of full recovery of mitochondrial respiration is
complete assembly of the respirasome and CII, which are
directly linked to efficient tumor formation. This shows that
tumor cells with compromised respiration due to mtDNA
deletion are capable of in vivo mitochondrial genome acqui-
sition and demonstrates that mitochondrial respiration is
required for tumorigenesis in these models. Mitochondrial
DNA mutations can also contribute to tumorigenesis, sug-
gesting that optimum bioenergetic balance may relate to
the individual tumor (Tan et al., 2014). Our results support
the notion of tumor plasticity and the exceptional ability ofFigure 6. Mitochondrial DNA Content and Transcriptional Activity of 4
(A) 4T1 cells and derived sublines were evaluated for mtDNA/nDNA ratio using qP
using cells maintained in culture for a short period of time (first analysis), 1 month (s
the level of RC transcripts encoded by mtDNA (B) and nDNA (C) and for transc
(Supplemental Information). Data are from three independent experiments, and
differences with p < 0.05.
Ctumors to overcome unfavorable circumstances (Hanahan
and Weinberg, 2011).
EXPERIMENTAL PROCEDURES
Cell Culture, Tumor Formation, and Establishment of Tumor-
Derived Cell Lines
B16- and 6TG-resistant 4T1 cells from ATCCwere used andmaintained in cul-
ture as described in the Supplemental Information. For the preparation of r0
cells, parental tumor cell lines were cultured for 10–12 weeks in low-dose
EtBr (50–100 ng/ml) supplemented with 1 mM pyruvate and 50 mg/ml uridine
(King and Attardi, 1989) followed by transfer to medium lacking EtBr. Loss of
mtDNA was monitored by sensitivity to 2 mM FCCP (Herst and Berridge,
2007; Herst et al., 2011), PCR analysis of the mitochondrial Cytb gene, and
by pyruvate/uridine auxotrophy. With 6TG-resistant 4T1 cells, cell lines were
derived from primary s.c. tumors, mammary fat pad, circulating tumor cells,
and from the lungs of mice 4–6 weeks after injection with 4T1r0 cells, by selec-
tion in the presence of 60 mM6TG for 7–10 days. With the B16 model, cell lines
were derived from primary s.c. tumors and from the lungs of mice injected with
B16r0 cells by long-term culture. Tumor cells rapidly outgrew nontumor cells in
these cultures, and B16r0-derived cell lines have been maintained as stable
lines for over 2 years.
Mitochondrial Isolation and Sequence Analysis
Mitochondria for respiration studies were isolated according to Schmitt et al.
(2013), and mtDNA tRNAArg sequencing was carried out on a PCR-amplified
region using Sanger sequencing. Whole mtDNA sequencing used overlapping
PCR-amplified products and both Ion Torrent and Nanopore MinION ap-
proaches using whole mtDNA sequencing.
Microscopic and Flow Cytometric Cell Evaluation
Standard methodology (see Supplemental Information) was used for bright
field and fluorescence microscopy and TEM, while flow cytometry used BD
FACSCalibu and FACSCanto instruments.
Respiration Assays
Oxygen consumption by dispersed tumor tissue and liver tissue from the same
mice, and by B16, 4T1, B16r0, and 4T1r0 and derived cell lines was evaluated
with cells suspended in RPMI1640 medium without serum using Oxygraph-2k
(Oroboros Instruments) and published procedures (Pesta and Gnaiger, 2012),
as detailed in the Supplemental Information. Respiration by specificmitochon-
drial complexes was evaluated using digitonin-permeabilized cells as
described in the Supplemental Information.
Mitochondrial Biochemistry Assays and Gene Expression Analysis
Mitochondrial membrane potential and ROS production were assessed by
flow cytometry using the fluorescent probes TMRM, DCF-DA, and MitoSOX.
Glucose uptake was assessed using 2-NGDG, ATP using a luciferase-based
assay, and lactate colorimetrically. Cytb was measured by PCR, while gene
expression analysis used qRT-PCR. WB and NBGE used well-established
methods, while newly synthesized mitochondrial proteins were evaluated us-
ing a Clik-iT AHA kit followed by WB. CS and SDH/SQR activities were as-
sessed using established protocols as described in the Supplemental
Information.
Statistical Analysis
Unless stated otherwise, data are mean ± SD of at least three independent
experiments and used groups of five mice. The two-tailed unpaired Student’s
t test was used to assess statistical significance with p < 0.05 being regardedT1r0 Sublines
CR and specific primers (Supplemental Information). Analyses were performed
econd analysis), and 4months (third analysis). Sublines were also evaluated for
ripts of mitochondrial regulatory genes (D) using qPCR and specific primers
the results are expressed as mean ± SD. The symbol * denotes significant
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Figure 7. Mitochondrial Protein Synthesis, Respiratory Complex Formation, and Supercomplex Assembly in 4T1r0 Sublines
(A) 4T1 cells and derived sublines were evaluated for newly synthesized proteins using the Clik-iT AHA kit. Sublines were assessed for CS (B), SDH (C), and SQR
activity (D) as detailed in Experimental Procedures, as well as for expression of specific proteins using WB (E). Tubulin was used as a loading control. (F) The
mitochondrial fraction was lysed in the presence of digitonin and subjected to NBGE. Specific subunits of individual complexes were detected using the anti-
bodies shown. HSP60was used as a loading control. The level of expression of the individual bands representing RCs, subcomplexes, and SCswas evaluated by
densitometry relative to HSP60. Data are from three independent experiments, and the results are expressed as mean ± SD. The symbol * denotes significant
differences with p < 0.05.
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as significant. Images are representative of three independent experiments.
For TEM data, Tukey’s multiple comparison procedure and statistical test
was used at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2014.12.003.
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